Clinical Trial

Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Head and Neck Squamous Cell Carcinoma (HNSCC)

Study acronym: WEBNECK
Recruiting
View on ClinicalTrials.gov →
Summary
The use of digital strategies to systematically monitor patients' symptoms in clinical settings allows problems to be detected at an early stage before they worsen or lead to complications. In this study, the hypothesis is that the proportion of patients with a weight loss of at least 5% between before radiotherapy/radiochemotherapy and 3 months after treatment would be lower with optimised care thanks to remote monitoring using a medical telemonitoring solution in oncology.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-17.
Status change: Not Yet Recruiting → Recruiting 2025-12-29
Trial Details
NCT Number NCT07190755
Lead Sponsor Centre Henri Becquerel
Collaborators: Resilience
Conditions Head and Neck Squamous Cell Carcinoma HNSCC
Enrollment 192 participants
Start Date 2025-10-15
Primary Completion 2030-06-01 (estimated)
Study Completion 2030-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-30